Day One Biopharmaceuticals, Inc. ($DAWN)
Filing Information
| Accession Number | 0001655962-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 15, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
52,815
Total Value
$70,359.46
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COO and CFO | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 2,250 | โ | โ | 296,965 | Direct | โ | View Details | |
COO and CFO | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 6,625 | โ | โ | 303,590 | Direct | โ | View Details | |
COO and CFO | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 6,625 | โ | โ | 310,215 | Direct | โ | View Details | |
COO and CFO | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 7,875 | โ | โ | 318,090 | Direct | โ | View Details | |
COO and CFO | Common Stock | โ | Feb 17, 2026 | Sale | 6,065 | $11.60 | $70,359.46 | 312,025 | Direct | โ | View Details | |
COO and CFO | Restricted Stock Unit (RSU) | Derivative | Feb 15, 2026 | Exercise/Conversion | 2,250 | $0.00 | $0.00 | 6,750 | Direct | โ | View Details | |
COO and CFO | Restricted Stock Unit (RSU) | Derivative | Feb 15, 2026 | Exercise/Conversion | 6,625 | $0.00 | $0.00 | 46,375 | Direct | โ | View Details | |
COO and CFO | Restricted Stock Unit (RSU) | Derivative | Feb 15, 2026 | Exercise/Conversion | 6,625 | $0.00 | $0.00 | 72,875 | Direct | โ | View Details | |
COO and CFO | Restricted Stock Unit (RSU) | Derivative | Feb 15, 2026 | Exercise/Conversion | 7,875 | $0.00 | $0.00 | 118,125 | Direct | โ | View Details |